SCHEMBL7657349

SCHEMBL7657349

CCOc1ccc(OCC[O])cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 1/20 0.67
KDM4E B2RXH2 3/20 0.55
ALDH1A1 P00352 2/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
TDP1 Q9NUW8 2/20 0.54
TSHR P16473 1/20 0.54
LTA4H P09960 2/20 0.50
PARP10 Q53GL7 1/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA7 P43166 1/20 0.50
CA9 Q16790 1/20 0.50
LMNA P02545 2/20 0.47
NPC1 O15118 1/20 0.47
PLK1 P53350 1/20 0.47
POLB P06746 1/20 0.47
MEN1 O00255 1/20 0.47
CYP1A2 P05177 1/20 0.47
KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1,4-Diethoxybenzene SCHEMBL124015 0.82 NQO1 (1.00) NQO1KDM4EALDH1A1SMN1; SMN2TDP1
1,4-Diethoxybenzene SCHEMBL28186701 0.82 NQO1 (1.00) NQO1KDM4EALDH1A1SMN1; SMN2TDP1
SCHEMBL3332304 0.81 MAPT (0.55) SMN1; SMN2TDP1CA12CA1CA2
SCHEMBL6516595 0.81 L3MBTL1 (0.59) KDM4EALDH1A1SMN1; SMN2TDP1TSHR
SCHEMBL14984021 0.80 NQO1 (0.74) NQO1KDM4EALDH1A1SMN1; SMN2TDP1
1-Butyloxy-4-Ethoxybenzene SCHEMBL14695816 0.80 NQO1 (0.74) NQO1KDM4EALDH1A1SMN1; SMN2TDP1
4-Ethoxy-1-Propoxybenzene SCHEMBL2841577 0.80 NQO1 (0.74) NQO1KDM4EALDH1A1SMN1; SMN2TDP1
SCHEMBL9517801 0.79 MAPT (0.48) KDM4EMAPTL3MBTL1RECQL
1,4-Diethoxybenzene SCHEMBL11794798 0.79 NQO1 (0.93) NQO1KDM4EALDH1A1SMN1; SMN2TDP1
SCHEMBL8062711 0.78 NQO1 (0.70) NQO1KDM4EALDH1A1SMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020165232-A1 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity SIKORSKI JAMES A (US) 2002-11-07 US claimed
US-6458803-B1 COMPOSITIONS AND METHODS FOR TREATING ATHEROSCLEROSIS AND OTHER CORONARY ARTERY DISEASES. PREFERRED TERTIARY-HETEROALKYLAMINE COMPOUNDS ARE SUBSTITUTED N-PHENYL-N-HETEROARALKYL AMINOALCOHOLS. A PREFERRED SPECIFIC G.D. SEARLE & CO. 2002-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020165232-A1 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity CETP, DBI, PLTP NQO1 2619/4885KDM4E 3603/4885ALDH1A1 2588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.